{
    "SPADE_N_03148": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2003/0092612 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2003_0092612_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2003-5-15",
                "Family Info": "CA2451469A1,EP1406647A1,EP1406647A4,US6872705,WO2003006046A1",
                "Patent Title": "Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions.",
                "Abstract": "Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
            },
            {
                "Patent No": "US 6872705 B2",
                "Patent Link": "http://www.lens.org/lens/patent/US_6872705_B2",
                "Patent Type": "Granted Patent",
                "Publication Date": "2005-3-29",
                "Family Info": "US4525346,US6372234,US6482799",
                "Patent Title": "Use Of Antimicrobial Peptides As Preservatives In Ophthalmic Preparations, Including Solutions, Emulsions, And Suspensions",
                "Abstract": "Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially nonoxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03148",
            "Peptide Name": "Neutrophil defensin 1 (Defensin, alpha 1; HNP-1, HP-1; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the alpha-defensin family",
            "Gene": "DEFA1, DEFA1B",
            "Sequence": "ACYCRIPACIAGERRYGTCIYQGRLWAFCC",
            "Sequence Length": 30,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P59665",
                "http://www.uniprot.org/uniprot/P11479",
                "http://www.uniprot.org/uniprot/Q14125",
                "http://www.uniprot.org/uniprot/Q6EZF6"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 μg/mL (290 nM));SARS-CoV-2 variant P.1:inhibition of infection in HeLa-hACE2 cells(67% inbibition at 50 μg/mL);SARS-CoV-2 variant B.1.1.7:inhibition of infection in HeLa-hACE2 cells(58% inbibition at 50 μg/mL).[Ref.15616305] Gram-negative bacteria:Escherichia coli ATCC 8739 (vLD50=3.6±0.3 μg/ml), E. coli ATCC 25922 (vLD50=3.7±0.4 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=10±0.5 μg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (vLD50=4.2±1.0 μg/ml), Staphylococcus aureus ATCC 29213 (vLD50=2.1±0.3 μg/ml), Bacillus cereus ATCC 10876 (vLD50=0.22±0.03 μg/ml).NOTE:vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).[Ref.15118082]Gram-positive bacteria:Bacillus subtilis (Inhibition zone=24 mm in PH5.5, Inhibition zone=20 mm in PH7.5 completely inhibit at 10 μg/well), Staphylococcus aureus  (Inhibition zone=1 mm in PH5.5, Inhibition zone=7 mm incompletely inhibit and Inhibition zone=2 mm completely inhibit in PH7.5 at 10 μg/well);Gram-negative bacteria:Escherichia coli (Inhibition zone=5 mm incompletely inhibit and Inhibition zone=2 mm completely inhibit in PH7.5 at 10 μg/well);Fungi:Candida albicans (Inhibition zone=13 mm in PH5.5, Inhibition zone=10 mm in PH7.5 completely inhibit at 10 μg/well).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 μg/mL.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Cyclization(Cys2 and Cys30).",
            "Stereochemistry": "L",
            "Structure Description": "Compared to HNP-2, HNP-1 contains one additional residue (Ala) at the N-terminus. It contains a long stretch of a double-stranded antiparallel beta-sheet in a hairpin conformation that contains a beta-bulge, a short region of triple-stranded beta-sheet, and several tight turns.",
            "Formula": "C150H228N44O38S6",
            "Mass": 3448.08,
            "PI": 8.68,
            "Net Charge": 3,
            "Hydrophobicity": 0.3,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Defensin 1 and defensin 2 have antibacterial, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.",
            "PTM": "ADP-ribosylation drastically reduces cytotoxic and antibacterial activities, and enhances IL8 production. Phosphorylation at Tyr-85 has been found in some cancer cell lines, and interferes with ADP-rybosylation.",
            "Literature": [
                {
                    "Title": "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.",
                    "Pubmed ID": "34206990",
                    "Reference": "Viruses. 2021 Jun 26;13(7)1246.",
                    "Author": "Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34206990"
                },
                {
                    "Title": "Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.",
                    "Pubmed ID": "19253295",
                    "Reference": "Proteomics. 2009 Mar;9(5)1364-1373.",
                    "Author": "Stegemann C, Kolobov A Jr, Leonova YF, Knappe D, Shamova O, Ovchinnikova TV, Kokryakov VN, Hoffmann R.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=19253295"
                },
                {
                    "Title": "Antibacterial activity and specificity of the six human {alpha}-defensins.",
                    "Pubmed ID": "15616305",
                    "Reference": "Antimicrob Agents Chemother. 2005 Jan;49(1)269-275.",
                    "Author": "Ericksen B, Wu Z, Lu W, Lehrer RI.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15616305"
                },
                {
                    "Title": "Multidimensional signatures in antimicrobial peptides.",
                    "Pubmed ID": "15118082",
                    "Reference": "Proc Natl Acad Sci U S A. 2004 May 11;101(19)7363-8.",
                    "Author": "Yount NY, Yeaman MR.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15118082"
                },
                {
                    "Title": "Isolation and characterization of human defensin cDNA clones.",
                    "Pubmed ID": "",
                    "Author": "Kronenberg M.,Ganz T.,Lehrer R.I.,Daher K.A."
                },
                {
                    "Title": "A myeloid-related sequence that localizes to human chromosome 8q21.1-22.",
                    "Pubmed ID": "",
                    "Author": "Saunders G.F.,White J.W.,Drabkin H.A.,vanTuinen P.,Mars W.M."
                },
                {
                    "Title": "Differentiation stage-specific expression of a gene during granulopoiesis.",
                    "Pubmed ID": "",
                    "Author": "Winnie J.N.,Burns J.H.,Lamb R.F.,Francis G.E.,Wiedemann L.M."
                },
                {
                    "Title": "Inheritance of unequal numbers of the genes encoding the human neutrophil defensins HP-1 and HP-3.",
                    "Pubmed ID": "",
                    "Author": "Weil M.M.,Huff V.,Maity T.,Patmasiriwat P.,Mars W.M."
                },
                {
                    "Title": "The structure of neutrophil defensin genes.",
                    "Pubmed ID": "",
                    "Author": "Ganz T.,Liu L.,Michaelson D.,Linzmeier R."
                },
                {
                    "Title": "",
                    "Pubmed ID": "",
                    "Author": "Ganz T.,Liu L.,Michaelson D.,Linzmeier R."
                },
                {
                    "Title": "Primary structures of three human neutrophil defensins.",
                    "Pubmed ID": "",
                    "Author": "Lehrer R.I.,Schilling J.W.,Ganz T.,Harwig S.S.L.,Selsted M.E."
                },
                {
                    "Title": "Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide.",
                    "Pubmed ID": "",
                    "Author": "Harwig S.S.L.,Selsted M.E."
                },
                {
                    "Title": "The isolation and identification of multiple forms of the neutrophil granule peptides from human leukemic cells.",
                    "Pubmed ID": "",
                    "Author": "Solomon S.,Mars W.M.,Shustik C.,Singh A.,Bateman A."
                },
                {
                    "Title": "Posttranslational processing of defensins in immature human myeloid cells.",
                    "Pubmed ID": "",
                    "Author": "Ganz T.,Valore E.V."
                },
                {
                    "Title": "NMR studies of defensin antimicrobial peptides. 1. Resonance assignment and secondary structure determination of rabbit NP-2 and human HNP-1.",
                    "Pubmed ID": "",
                    "Author": "Pardi A.,Selsted M.E.,Zhang X.-L."
                },
                {
                    "Title": "NMR studies of defensin antimicrobial peptides. 2. Three-dimensional structures of rabbit NP-2 and human HNP-1.",
                    "Pubmed ID": "",
                    "Author": "Yip P.F.,Skalicky J.J.,Selsted M.E.,Zhang X.-L.,Pardi A."
                },
                {
                    "Title": "DNA sequence and analysis of human chromosome 8.",
                    "Pubmed ID": "R2006J0476",
                    "Author": "Taudien S.,Asakawa S.,Zody M.C.,Mikkelsen T.S.,Nusbaum C."
                },
                {
                    "Title": "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).",
                    "Pubmed ID": "R2004J1449",
                    "Author": ""
                },
                {
                    "Title": "Signal peptide prediction based on analysis of experimentally verified cleavage sites.",
                    "Pubmed ID": "R2004J1198",
                    "Author": "Henzel W.J.,Zhang Z."
                },
                {
                    "Title": "Antibacterial activity and specificity of the six human alpha-defensins.",
                    "Pubmed ID": "R2005J0141",
                    "Author": "Lehrer R.I.,Lu W.,Wu Z.,Ericksen B."
                },
                {
                    "Title": "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.",
                    "Pubmed ID": "R2007J0581",
                    "Author": "Yu J.,Possemato A.,Zeng Q.,Guo A.,Rikova K."
                },
                {
                    "Title": "Structural and functional consequences induced by post-translational modifications in alpha-Defensins.",
                    "Pubmed ID": "R2011J1259",
                    "Author": "Talluri E.,Pogni R.,Picchianti M.,Bonucci A.,Balducci E."
                },
                {
                    "Title": "Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs.",
                    "Pubmed ID": "R2007J1495",
                    "Author": "Li C.,Pazgier M.,Li C.,de Leeuw E.,Zou G."
                }
            ],
            "Frequent Amino Acids": "CAR",
            "Absent Amino Acids": "DHKMNOSUV",
            "Basic Residues": 4,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 14,
            "Polar Residues": 19,
            "Positive Residues": 4,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03111",
                    "Similarity": 1.0,
                    "Sequence": "DIPEVVVSLAWDESLAPKHPGSRKNMACYCRIPACIAGERRYGTCIYQGRLWAFCC"
                },
                {
                    "SPADE_ID": "SPADE_N_08050",
                    "Similarity": 1.0,
                    "Sequence": "MRTLAILAAILLVALQAQAEPLQARADEVAAAPEQIAADIPEVVVSLAWDESLAPKHPGSRKNMACYCRIPACIAGERRYGTCIYQGRLWAFCC"
                },
                {
                    "SPADE_ID": "SPADE_UN_30122",
                    "Similarity": 1.0,
                    "Sequence": "ACYCRIPACIAGERRYGTCIYQGRLWAFCC"
                }
            ]
        }
    }
}